All live session recordings are now available for CHEST 2020 registrants through the “Live Sessions” section of CHEST 2020 lobby.
Please note: This agenda only shows the live CHEST 2020 sessions.
View the CHEST 2020 On Demand sessions.
In this session we will briefly review the key components of PAP downloads and then delve into clinical cases where utilizing the PAP download can help to treat the patient. The learners in the room will actively work through the cases with the faculty using the audience response system. We will cover both pediatric and adult patients, basic...
Opioids use has increased dramatically in recent decades, and is now considered a health care crisis. The goal of this session is to help pulmonary providers appreciate the scope of the opioid epidemic and its specific relevance to our patients. Experts will give an overview of the opioid epidemic from a public health standpoint and highlight implications for providers in pulmonary, critical care, and sleep medicine. Specific topics to...
This plenary session will comprise of four short presentations to introduce the role of circadian rhythms in health and disease to chest clinicians. The first presentation will describe the genetic and molecular processes governing circadian rhythms that impact physiology and behavior. The subsequent presentations will highlight the latest findings relating to the relevance of circadian rhythms in commonly treated conditions such as asthma, ICU delirium, and cancer. The use of...
Sleep-disordered breathing (SDB) is very common in CHF and includes both obstructive sleep apnea (OSA) and central sleep apnea-Cheyne Stokes respiration (CSA-CSR). OSA can worsen heart function and also CHF-related disease outcomes. CSA-CSR is a likely consequence of CHF. Both CSA and OSA can cause...
All original research presentation content for CHEST 2020 is embargoed until October 12.
Obesity hypoventilation syndrome is the most severe form of chronic respiratory compromize in obese individuals. Untreated, this syndrome is associated with increased risk of pulmonary HTN, poor quality of life, and increased readmission rate. New guidelines for management of these patients were published in August 2019. For many of us, these...
Given the high prevalence of sleep-related breathing disorders, understanding the pathophysiology of obstructive sleep apnea and central sleep apnea has become important to the effective treatment for these disorders. Often OSA and CSA coexist and treatments of OSA may further the development of CSA. Understanding of the overlaps in the physiology of CSA/OSA occurrence, their interplay and temporal evolution can help the practitioner treat patients afflicted with these problems better.
All original research presentation content for CHEST 2020 is embargoed until October 12.
This session will review the concept of OSA phenotypes/endotypes, emphasizing how we might be able to personalize therapy for OSA, offering CPAP alternatives at the outset of the treatment plan as opposed to the current practice of considering these in CPAP failures. Subsessions will discuss established alternative treatment options of hypoglossal nerve stimulation and mandibular advancement devices and review recent outcome data on their efficacy on cardiovascular outcomes. There will also be a session on...
The CHEST 2020 schedule is subject to change.